Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

Clinical trial NCT00417287 · TERMINATED

Trial details

NCT number: NCT00417287
Sponsor: Cascadian Therapeutics Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms

Start date: 2006-12-01
Primary completion: 2009-04-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.